Converting wound scar into healing with regeneration
通过再生将伤口疤痕转化为愈合
基本信息
- 批准号:10359160
- 负责人:
- 金额:$ 46.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAgonistBindingCell Differentiation processCellsChIP-seqCicatrixCuesDataDermalDermisDevelopmentDevelopmental BiologyExcisionFailureFibroblastsFibrosisFutureGeneticGenetic TranscriptionGoalsGrantHair follicle structureHumanHypersensitivity skin testingImmunohistochemistryInjuryInvestigationLeadLigandsMammalsMediatingMolecular TargetMusMyofibroblastNatural regenerationOutcomePathway interactionsPhenotypePlayProcessReceptor SignalingRecombinant ProteinsRegenerative MedicineRegulationRegulator GenesRoleSHH geneSignal PathwaySignal TransductionSiteSkinSkin CancerSkin graftTestingTissuesTransfectionUp-RegulationViralWNT Signaling PathwayWound modelsXenograft ModelXenograft procedureappendagebasebeta cateninbone morphogenetic protein receptorsexperimental studygain of functionhealinghuman tissueimprovedloss of functionnovel strategiespreventrecombinant virusregeneration potentialregenerativeregenerative biologyrepairedresponsesingle-cell RNA sequencingskin regenerationskin woundsmoothened signaling pathwaysynergismtongue papillatraittranscriptome sequencingwoundwound environmentwound healing
项目摘要
Summary
The goal of this grant is to understand the role of SHH signaling in regulation of regenerative healing in
mammalian skin wounds. Most mammals including humans are deficient in regenerative skin healing. After
injury, wound healing typically results in 'repair' (also defined as fibrosis/scarring). This process fails to fully
restore the lost tissue to its original form, resulting in “a cellular band-aid”. The inability of mammals to regenerate
normal skin is most notably illustrated by the lack of skin appendages including hair follicles in the wound scar. A
major hurdle in hair follicle regeneration in skin wounds is the failure to reestablish the hair follicle inductive niche
known as the dermal papilla (DP).
Here, we show that SHH activation within 'repaired' (scarring) wound dermis induces de novo DP
formation leading to HFN. These data clearly demonstrate that myofibroblasts within scarring wounds are not
intrinsically incapable of forming the regenerative niche. We hypothesize that scarring cells may possess
the regenerative potential but are missing the crucial developmental cue, SHH. To address this
hypothesis, first, we will ask if Wnt signaling, which is active in fibrotic wounds, is required for SHH-driven DP
formation and resultant HFN in wounds. For this we will perform loss-of-function studies on b-catenin, an
essential effector of canonical Wnt signaling, in genetically modified wounds with ectopic SHH activation
(Aim1). We will also examine the potential of mature Wnt-active fibroblasts to convert to DP in Hh-activated
wounds after healing is complete. These experiments will address the potential plasticity of fully differentiated
cells and how induction by the Hh pathway may alter their phenotype (Aim 1). Second, preliminary single cell
RNAseq analyses comparing Hh-activated and WT wounds have identified downstream expression of several
BMPs following Hh activation. We will examine the role of BMP signaling in mediating the function of Hh signaling
through loss- and gain-of-function studies on BMP receptor signaling. We will also examine the ability of
immediate Hh regulators Gli1 and 2, to directly bind BMP gene regulatory sites by Chip-Seq analysis (Aim
2). Third, human wounds strongly resemble 'repaired' murine wounds in many traits. We will test whether
human wounds can respond to SHH signals to produce DP by introducing viral active-SmoM2 or soluble SHH
agonists into xenograft-and-wounding models. Importantly, we will delineate the response of human dermal cells
to SHH through single cell RNAseq analyses, and also compare these results with those from murine wounds
(Aim3). These combined studies will advance our understanding of the mechanisms required to induce hair
follicle regeneration in an otherwise hairless wound environment and will provide essential new information about
how human wounds may compare with murine wounds and be manipulated for improved healing.
概括
这笔赠款的目的是了解SHH信号在调节再生治疗中的作用
哺乳动物皮肤伤口。包括人类在内的大多数哺乳动物都缺乏再生皮肤愈合。后
受伤,伤口愈合通常会导致“修复”(也定义为纤维化/疤痕)。这个过程无法完全
将丢失的组织恢复为原始形式,从而导致“细胞创可贴”。哺乳动物无法再生
正常的皮肤是由于缺乏皮肤附属物在内的包括伤口疤痕中的毛发毛的附属物所说明的。一个
皮肤伤口中毛发再生的主要障碍是未能重新建立头发叶片感应的小众
被称为真皮乳头(DP)。
在这里,我们表明“修复”(疤痕)伤口真皮诱导的shh激活dp dp
形成导致HFN。这些数据清楚地表明,疤痕伤口中的肌纤维细胞不是
本质上无法形成再生生态位。我们假设疤痕细胞可能拥有
再生潜力,但缺少关键的发展提示,嘘。解决这个问题
假设,首先,我们将询问SHH驱动的DP是否需要在纤维化伤口中活跃的Wnt信号传导
伤口中的形成和由此导致的HFN。为此,我们将对B-catenin进行功能丧失研究,
在具有生态SHH激活的转基因伤口中,规范Wnt信号的基本效应器
(AIM1)。我们还将检查成熟的Wnt活性成纤维细胞在HH激活中转化为DP的潜力
愈合后的伤口完成。这些实验将解决完全分化的潜在可塑性
细胞以及HH途径诱导如何改变其表型(AIM 1)。其次,初步单细胞
RNASEQ分析比较HH激活和WT伤口的RNASEQ分析已经确定了几种的下游表达
HH激活后的BMP。我们将检查BMP信号在介导HH信号功能中的作用
通过对BMP受体信号传导的丧失和功能性研究。我们还将研究
立即进行HH调节剂GLI1和2,通过CHIP-SEQ分析直接结合BMP基因调节位点(AIM
2)。第三,人的伤口在许多特征中强烈类似于“修复”的鼠伤口。我们将测试是否
人的伤口可以通过引入病毒活性-SMOM2或固体SHH来响应SHH信号以产生DP
激动剂变成Xenographicang and-nounging模型。重要的是,我们将描述人真皮细胞的反应
通过单细胞RNASEQ分析进行SHH,并将这些结果与鼠伤口的结果进行比较
(AIM3)。这些合并的研究将提高我们对诱导头发所需机制的理解
在原本无毛伤口环境中的叶片再生,将提供有关的基本新信息
人的伤口如何与鼠风相比,并被操纵以改善愈合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mayumi Ito其他文献
Mayumi Ito的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mayumi Ito', 18)}}的其他基金
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
项目 2:基质微环境对早期传播的贡献
- 批准号:
10414445 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Project 2: Contribution of the Stromal Microenvironment to Early Dissemination
项目 2:基质微环境对早期传播的贡献
- 批准号:
10705081 - 财政年份:2022
- 资助金额:
$ 46.71万 - 项目类别:
Converting wound scar into healing with regeneration
通过再生将伤口疤痕转化为愈合
- 批准号:
10113542 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Converting wound scar into healing with regeneration
通过再生将伤口疤痕转化为愈合
- 批准号:
10576296 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Converting wound scar into healing with regeneration
通过再生将伤口疤痕转化为愈合
- 批准号:
9887451 - 财政年份:2020
- 资助金额:
$ 46.71万 - 项目类别:
Exploiting skin fibroblasts to promote digit tip regeneration upon amputation
利用皮肤成纤维细胞促进截肢后指尖再生
- 批准号:
9912481 - 财政年份:2019
- 资助金额:
$ 46.71万 - 项目类别:
Induction of digit regeneration by Wnt active nail epithelium
Wnt活性指甲上皮诱导手指再生
- 批准号:
8815502 - 财政年份:2014
- 资助金额:
$ 46.71万 - 项目类别:
Characterization of early events in bulge McSCs and their progeny during melanoma
黑色素瘤期间凸起的 McSC 及其后代的早期事件特征
- 批准号:
8701564 - 财政年份:2014
- 资助金额:
$ 46.71万 - 项目类别:
Induction of digit regeneration by Wnt active nail epithelium
Wnt活性指甲上皮诱导手指再生
- 批准号:
9542711 - 财政年份:2014
- 资助金额:
$ 46.71万 - 项目类别:
Characterization of early events in bulge McSCs and their progeny during melanoma
黑色素瘤期间凸起的 McSC 及其后代的早期事件特征
- 批准号:
8843438 - 财政年份:2014
- 资助金额:
$ 46.71万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Microglial process convergence following brain injury
脑损伤后小胶质细胞过程收敛
- 批准号:
10657968 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Modeling genetic contributions to biliary atresia
模拟遗传对胆道闭锁的影响
- 批准号:
10639240 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Evaluating the efficacy of a novel NASH therapeutic
评估新型 NASH 疗法的疗效
- 批准号:
10698971 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别:
Visinin-like protein-1 modulation of nicotinic receptors
Visinin 样蛋白-1 烟碱受体的调节
- 批准号:
10712709 - 财政年份:2023
- 资助金额:
$ 46.71万 - 项目类别: